Real-world data advantage Verana Health specializes in real-world data (RWD) across oncology, ophthalmology, neurology, and urology with exclusive data access, presenting a strong opportunity to offer data collaborations, insights services, and regulatory-grade datasets to life sciences companies.

Expanded datasets Recent launches of updated bladder cancer and expanded ovarian cancer datasets indicate a momentum in growing data assets, suggesting cross-sell potential to researchers and sponsors seeking broader or more granular real-world evidence.

End-to-end trial support New functionality in Site Explorer and Verana Trial Connect enables end-to-end site selection and patient enrollment transparency, presenting a compelling upsell for sponsors and CROs needing streamlined trial operations and measurable performance.

AI-driven data submission Development of Agent Claire to assist practices with Merit-based Incentive Payment System data submission signals an opportunity to partner on AI-enabled data capture workflows, driving adoption among clinics and payer-related programs.

Strategic partnerships Alliances such as the Guardant Health partnership unlock access to integrated clinicogenomic data and curated EHR datasets, highlighting a path for joint offerings to biopharma customers seeking comprehensive real-world evidence and genomic context.